Advertisement · 728 × 90
#
Hashtag
#PTLD
Advertisement · 728 × 90
Post image

Systematic Review of #Immunosuppression after #CAR-T Therapy for #PTLD

#VisualAbstract by Edgar V. Lerma 🇵🇭

www.kireports.org/article/S2468-0249(26)02...

3 1 0 0
Preview
Psilocybin Passes First Tests: Improves Symptoms in Fibromyalgia and Post Treatment Lyme Disease - Health Rising Geoff’s Narration The GIST   “These substances represent a potentially revolutionary approach to pharmacological pain management,” Crozpek et. Al. 2025 History has shown that our notions of what treat...

Psilocybin Passes First Tests: Improves Symptoms in Fibromyalgia and Post Treatment Lyme Disease #FM #PTLD www.healthrising.org/blog/2026/03...

11 3 1 1
Post image

Conducting chronic respiratory disease research in low- and middle-income countries? We have a new journal for you.

Be sure to read the inaugural issue of IJTLD Chronic Respiratory Disease: journals.theunion.org/content/ijtl...

#asthma #COPD #PTLD #bronchiectasis #longCOVID

1 0 0 0
Post image

On #RareDiseaseDay, we recognise that rare diseases are an important part of the post-transplant landscape.
At ESOT, we remain focused on advancing research and improving outcomes for transplant recipients. ​

@rarediseaseday.bsky.social #OrganTransplantation #PTLD

2 0 0 0
IJTLD Chronic Respiratory Disease IJTLD Chronic Respiratory Disease (IJTLD CRD) is open access and fully compliant with Plan S, and features research on post TB lung disease (PTLD), asthma, COPD, impact of air pollution, lung damage in smokers,...

As a sister title to the IJTLD, we have now launched IJTLD CRD, focussed on chronic respiratory conditions in low- and middle-income countries. All articles are open access and free to read #asthma #COPD #airpollution #smoking #longcovid #bronchiectasis #PTLD journals.theunion.org/content/ijtl...

0 0 0 0
PhD student speaking with a microphone, presenting her work regarding the immune response to Epstein-Barr virus in multiple sclerosis and cancer.

PhD student speaking with a microphone, presenting her work regarding the immune response to Epstein-Barr virus in multiple sclerosis and cancer.

Glad to have presented my work at @cnb-csic.bsky.social, discussing the #EBV-specific immune response in the context of #multiplesclerosis.
Thank you to everyone who joined!

We will continue exploring EBV biology in my next stage in Boston, focusing on #PTLD

3 0 0 0

A bumper December issue of IJTLD Open for your festive reading #TB #PTLD #AMR www.ingentaconnect.com/content/iuat...

0 0 0 0
Preview
Latest Updates on Post-Transplant Lymphoproliferative Disorders (PTLD)

🎥 Webinar recording now available!
Catch up on the latest insights into PTLD, a rare and complex post-transplant condition.
Experts 🇫🇷🇧🇪🇩🇪 discuss pathogenesis, diagnosis, treatment & emerging therapies.
👉 Watch here: go.esot.org/sp_pf_replay

Supporting global awareness around #RareDiseaseDay
#PTLD

2 0 0 0
Preview
Latest Updates on Post-Transplant Lymphoproliferative Disorders (PTLD) with Chairs Sophie Caillard, France Olivier Thaunat, France and Panellists Daan Dierickx Nina Babel Marine Baron

Practical insights. Real expertise.​
Enhance your understanding of Post-Transplant Lymphoproliferative Disorders #PTLD in this focused 1-hour webinar.​
🔹 Chairs: Sophie Caillard & Olivier Thaunat​
🔹 Speakers: Daan Dierickx, Nina Babel​, Marine Baron

📅 TODAY
#TransplantCare #RareDisease

3 1 0 0
Preview
Latest Updates on Post-Transplant Lymphoproliferative Disorders (PTLD) with Chairs Sophie Caillard, France Olivier Thaunat, France and Panellists Daan Dierickx Nina Babel Marine Baron

Don’t miss it ⏭️NEXT Monday!
A focused 1h webinar on #PTLD, bringing you the latest on this 𝗿𝗮𝗿𝗲 post-transplant complication.

🎙️ Sophie Caillard • Olivier Thaunat • Daan Dierickx • Nina Babel • Marine Baron

👉 Save your spot: go.esot.org/sp_pf_ptld3nov
#RareDiseaseDay

0 0 0 0

Way to go #Ptld #NoKings
💙💙💙💙💙💙👏🏾👏🏾👏🏾👏🏾👏🏾

1 0 0 0

Holy crap the Republican feudalists just brought their war against the US to Oregon with "Full Force" engagement rules in #ptld . #kyr

2 0 1 0

✅ More than a twofold decrease in the risk of post-operative complications such as #PTLD, which often presents an oncological profile.

🩺 However, given the increased risk of organ rejection, careful patient monitoring and optimal dosing of therapy are essential.

0 0 1 0
Preview
Post-TB Community Call: Prof. Lisa Obimbo | Post-TB Community

On behalf of the TB Sequel consortium, PostTB Care & The Union, we’re delighted to invite you to the next Community Call on "Post-TB lung disease in children & adolescents, insights from an African perspective" by Prof. Lisa Obimbo

Wednesday, 10 September 2025
14:00–15:00 SAST

#Tuberculosis #PTLD

0 1 0 0

#PTLD onlinelibrary.wiley.com/doi/abs/10.1...

0 0 0 0
Preview
Screening and Management of PTLD : Transplantation plication following transplantation, with a mortality rate as high as 50% in transplant recipients. Therefore, it is important to establish for each transplant recipient a personalized risk evaluation...

#PTLD journals.lww.com/transplantjo...

0 1 1 0
Preview
Impact of antiviral prophylaxis on EBV viremia and posttransplant lymphoproliferative disorders in solid organ transplant recipients: a systematic review and meta-analysis - Virology Journal Introduction Organ transplant recipients face a substantial risk of developing posttransplant lymphoproliferative disorders (PTLD). In over 90% of cases with B‐cell PTLD following solid organ transpla...

#PTLD doi.org/10.1186/s129...

0 0 1 0
https://www.nature.com/articles/s41409-019-0548-7

#PTLD t.co/FOjInWqA43

0 0 1 0

#PTLD Treatment with antivirals has no effect.
Reduction of immunosuppression in solid organ transplants can lead to improvement. In stem cell transplants, rituximab has been used as therapy.

0 0 1 0

Immune mechanisms controlling proliferation of EBV infection in donor B cells are deficient, resembling “immortalization” of B cells when infected with EBV in vitro. Lymphocyte depleted grafts can result in delayed T cell chimerism, decreasing host resistance to viral infections #PTLD

0 0 1 0

Post-transplant lymphoproliferative disorder #PTLD seen in severely immunosuppressed.
Fever, lymphadenopathy & lymphomatous infiltrates in lymph nodes, spleen, liver, bone marrow, kidney & lung are typical.
Ref GWIDBR

0 0 1 0
Preview
Immune, metabolic, anatomical, and functional features of people after successful tuberculosis treatment: an exploratory analysis - Scientific Reports Scientific Reports - Immune, metabolic, anatomical, and functional features of people after successful tuberculosis treatment: an exploratory analysis

Detailed cross-sectional phenotyping of post-TB lung disease - PET-CT, spirometry, blood & BAL measurements.

Heterogeneous persisting inflammation, airway damage and impaired lung function.

Some correlations but which are causal? And which could be therapeutically inhibited?

#IDSky #TBSky #PTLD

9 4 0 0
Preview
Large numbers of TB survivors in SA struggling with lung damage, experts say There are over three million people alive in South Africa who have been cured of TB. But even after being cured, many continue to suffer the long-term after-effects of the disease. To find out more ab...

Did you know that #PostTB lung disease affects an estimated 60% of everyone who has been cured of #TB? This is a major silent crisis that needs more attention (bravo to team @tbproof.bsky.social for raising awareness). Learn more here 👇

www.spotlightnsp.co.za/2025/05/05/l...

#PTLD

2 1 0 0
Preview
Large numbers of TB survivors in SA struggling with lung damage, experts say | News24 Post-TB lung disease affects an estimated 60% of everyone who has been cured of TB. That is according to Dr Brian Allwood, a consultant pulmonologist at Stellenbosch University and Tygerberg Hospital....

60% of people cured of TB are left with long-term lung damage. Yet post-TB care remains neglected. As Dr Brian Allwood says, “It’s a silent crisis.” We need follow-up, support & systems that help survivors breathe and live better. #PTLD
www.news24.com/southafrica/...

1 1 1 0
Preview
Terapia cellulare: una possibilità per i disordini linfoproliferativi post trapianto Una complicanza che può insorgere nei pazienti sottoposti a trapianto che assumono immunosoppressori e che può essere trattata con la terapia cellulare.

Una nuova frontiera della #TerapiaCellulare per chi, dopo un trapianto d’organo, sviluppa disordini linfoproliferativi post trapianto #PTLD legati al virus di Epstein-Barr: per approfondire il tema ho intervistato il prof. Benedetto Bruno (Torino)

www.osservatorioterapieavanzate.it/terapie-avan...

0 0 0 0
Preview
Post-Tuberkulose-Lungenerkrankung: Neue Ansätze in Prävention und Behandlung Eine umfassende Übersichtsarbeit beleuchtet die langfristigen Folgen von Tuberkulose und den Bedarf an verbesserten Strategien im Umgang mit der Krankheit.

Das Institut für Infektions- & Tropenmedizin des @lmu-klinikum.bsky.social hat mit internationalen Partnern eine umfassende Übersicht zur Post-Tuberkulose-Lungenerkrankung veröffentlicht. #PTLD ist nicht infektiös, stellt jedoch eine erhebliche gesundheitliche & soziale Belastung dar. Mehr dazu:

4 1 0 0
Preview
Markers of cellular senescence is associated with persistent pulmonary pathology after COVID-19 infection The lungs are the organ most likely to sustain serious injury from coronavirus disease 2019 (COVID-19). However, the mechanisms for long-term complications are not clear. Patients with severe COVID...

HM9, runaway inflammation – often independently discussed, but as part of model of aging I found 9 #LC papers (tinyurl.com/ytww5h4u, tinyurl.com/ybc424kt) 9 #ME (tinyurl.com/2wzbwfbe, tinyurl.com/ysjrwa5d) & 4 #PTLD (tinyurl.com/2s4f3ukv) 12/26

1 0 1 0
Post image

Lyme patients deserve
EQUAL RECOGNITION
that is EQUITABLE
TO all OTHER
CRITICAL HEALTH CONDITIONS
in ALL PUBLIC LISTINGS.

FAILURE TO TREAT = HARM!!!

#Lyme
#LymeDisease
#LymeRightsNOW
#LymeReperations
#ChronicLyme
#LongLyme
#PTLD
#Bitten
#BioWeapon
#UnderOurSkin
#IDSACrymes

1 0 0 0
Post image

Lyme patients deserve
EQUAL RECOGNITION
that is EQUITABLE
TO all OTHER
CRITICAL HEALTH CONDITIONS
in ALL PUBLIC LISTINGS.

FAILURE TO TREAT = HARM!!!

#Lyme
#LymeDisease
#LymeRightsNOW
#LymeReperations
#ChronicLyme
#LongLyme
#PTLD
#Bitten
#BioWeapon
#UnderOurSkin
#IDSACrymes

0 0 0 0
Post image

Lyme patients deserve
EQUAL RECOGNITION
that is EQUITABLE
TO all OTHER
CRITICAL HEALTH CONDITIONS
in ALL PUBLIC LISTINGS.

FAILURE TO TREAT = HARM!!!

#Lyme
#LymeDisease
#LymeRightsNOW
#LymeReperations
#ChronicLyme
#LongLyme
#PTLD
#Bitten
#BioWeapon
#UnderOurSkin
#IDSACrymes

1 0 0 0